January 19, 2023

A recent study suggest that UDCA may help prevent Covid infection

ICE Pharma has been featured in an article in the Italian press, Il corriere della sera, concerning the huge increase in requirement for the drug Ursodeoxycholic acid in China. 

This surge in demand is linked to the new wave of SARS-cov-2 infections occurring since the lifting of restrictions in China and a study that recently appeared in the journal Nature, which suggests that UDCA may help prevent Covid infections or make its symptoms milder.

ICE Pharma is a leading global supplier of Ursodeoxycholic acid API with two manufacturing plants in Italy, one in Japan and one in India.

Tap on the link below to read the full paper that was published in Nature.